"The Institute gave us an opportunity to test our methods to see if they could work in practice instead of theory."

– Christopher Zarins, MD, Co-founder of HeartFlow

Portfolio

Since beginning operations in late 2007, The Fogarty Institute for Innovation has provided support to more than 10 innovative entrepreneurs in our “Innovation: Cultivation” program. HeartFlow, Niveus and PQ Bypass have moved on to establish independent offices. Our other innovators in residence are in various stages of development, but all are moving toward independence with astounding speed and efficiency.

Below is a summary of where each of our innovators stand to date in the development process.

In Residence
Company	Technology	Patient Benefit
	Point-of-care biologic treatments for cardiovascular disease. View company flyer	Outpatient treatment for non-revascularizable ischemic cardiac and vascular disease.
	Cost-effective total ear care system. View company flyer	Expand patient access and improve quality of ear care for the over 350M patients in need worldwide.
	Non-invasive proprietary light reflection technology to reliably and continuously monitor the fetus during labor and delivery.	Gives obstetricians greater ability to know when the fetus is at risk of neurological defect, such as cerebral palsy.
	Percutaneous approach to restoring valve competency in the deep leg veins. View company flyer	Cure for ulcers and other painful, debilitating complications in the legs due to poor vein function.
	Providing monitor-based, algorithm-driven medical guidance to caretakers of newborns immediately after birth. View company flyer	Improving newborn monitoring capability in the labor and delivery room.
	Miniaturized sewing machine for use in laparoscopic surgery. View company flyer	Allows surgeons the ability to place a continuous chain of stitches with a simple system.
	Web-based, interactive, engaging application for anatomy and physiology education. View company flyer	Better outcomes through education; broader patient and consumer access to health and wellness information.
Alumni
Company	Technology	Patient Benefit
	Patient-specific, non- invasive stenosis detection.	Eliminates ~1M invasive diagnostic procedures, reduces patient risk, and saves $13B/yr in healthcare costs.
	Novel treatment for mitral valve regurgitation. View company flyer	Minimally invasive treatment for mitral valve regurgitation vs. annuloplasty
	Electrical muscle stimulation for critical care patients. View company flyer	Prevents muscle deterioration in extended-duration critical care patients.
	Percutaneous treatment of peripheral vascular disease. View company flyer	Eliminates 200K highly invasive vascular bypass surgeries per year.